Skip to main content
Erschienen in: Clinical & Experimental Metastasis 1/2012

01.01.2012 | Research Paper

The involvement of NK cell activation following intranasal administration of CpG DNA lipoplex in the prevention of pulmonary metastasis and peritoneal dissemination in mice

verfasst von: Shuwen Zhou, Shigeru Kawakami, Yuriko Higuchi, Fumiyoshi Yamashita, Mitsuru Hashida

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Synthetic oligodeoxynucleotides containing CpG motifs (CpG DNA) can activate immunocompetent cells, which may possess antitumor activity. Previously, we found that when the cationic liposomes complexes formed with CpG DNA (CpG DNA lipoplex) were administered intranasally, they could prevent pulmonary metastasis in mice. However, the mechanisms underlying this process are unknown. In the present study, we show that natural killer (NK) cells play an important role in preventing pulmonary metastasis and peritoneal dissemination in a mouse model of metastatic disease. Further, in vitro, the NK cells obtained from mice treated with CpG DNA lipoplex showed higher cytotoxicity compared with untreated mice and in vivo, depletion of NK cells (achieved through injection of rabbit anti-asialo GM1 serum), abolished the inhibitory effect of CpG DNA lipoplex on pulmonary metastasis and peritoneal dissemination. In contrast, macrophage elimination did not disrupt the effects of the CpG DNA lipoplex. These results suggest that intranasal administration of CpG DNA lipoplex could prevent pulmonary metastasis and peritoneal dissemination by activating NK cells.
Literatur
1.
Zurück zum Zitat Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709–760PubMedCrossRef Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709–760PubMedCrossRef
2.
Zurück zum Zitat Krieg AM (2008) Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene 27(2):161–167PubMedCrossRef Krieg AM (2008) Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene 27(2):161–167PubMedCrossRef
3.
Zurück zum Zitat Nierkens S, den Brok MH, Roelofsen T et al (2009) Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice. PLoS One 4(12):e8368PubMedCrossRef Nierkens S, den Brok MH, Roelofsen T et al (2009) Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice. PLoS One 4(12):e8368PubMedCrossRef
4.
Zurück zum Zitat Kuramoto Y, Kawakami S, Zhou S et al (2008) Efficient peritoneal dissemination treatment obtained by an immunostimulatory phosphorothioate-type CpG DNA/cationic liposome complex in mice. J Control Release 126(3):274–280PubMedCrossRef Kuramoto Y, Kawakami S, Zhou S et al (2008) Efficient peritoneal dissemination treatment obtained by an immunostimulatory phosphorothioate-type CpG DNA/cationic liposome complex in mice. J Control Release 126(3):274–280PubMedCrossRef
5.
Zurück zum Zitat Kuramoto Y, Kawakami S, Zhou S et al (2009) Mannosylated cationic liposomes/CpG DNA complex for the treatment of hepatic metastasis after intravenous administration in mice. J Pharm Sci 98(3):1193–1197PubMedCrossRef Kuramoto Y, Kawakami S, Zhou S et al (2009) Mannosylated cationic liposomes/CpG DNA complex for the treatment of hepatic metastasis after intravenous administration in mice. J Pharm Sci 98(3):1193–1197PubMedCrossRef
6.
Zurück zum Zitat Ugwoke MI, Agu RU, Verbeke N et al (2005) Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev 57(11):1640–1665PubMedCrossRef Ugwoke MI, Agu RU, Verbeke N et al (2005) Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev 57(11):1640–1665PubMedCrossRef
8.
Zurück zum Zitat Zhou S, Kawakami S, Yamashita F et al (2010) Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice. Cancer Lett 287(1):75–81PubMedCrossRef Zhou S, Kawakami S, Yamashita F et al (2010) Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice. Cancer Lett 287(1):75–81PubMedCrossRef
9.
Zurück zum Zitat Schantz SP, Brown BW, Lira E et al (1987) Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol Immunother 25:141–148PubMedCrossRef Schantz SP, Brown BW, Lira E et al (1987) Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol Immunother 25:141–148PubMedCrossRef
10.
Zurück zum Zitat Vivier E, Tomasello E, Baratin M et al (2008) Functions of natural killer cells. Nat Immunol 9(5):503–510PubMedCrossRef Vivier E, Tomasello E, Baratin M et al (2008) Functions of natural killer cells. Nat Immunol 9(5):503–510PubMedCrossRef
11.
Zurück zum Zitat Siveen KS, Kuttan G (2009) Role of macrophages in tumour progression. Immunol Lett 123(2):97–102PubMedCrossRef Siveen KS, Kuttan G (2009) Role of macrophages in tumour progression. Immunol Lett 123(2):97–102PubMedCrossRef
12.
Zurück zum Zitat Moldoveanu Z, Love-Homan L, Huang WQ et al (1998) CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16(11–12):1216–1224PubMedCrossRef Moldoveanu Z, Love-Homan L, Huang WQ et al (1998) CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16(11–12):1216–1224PubMedCrossRef
13.
Zurück zum Zitat Pum PB, Bhat AA, Mohan T et al (2009) Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses. Int Immunopharmacol 9(4):468–477CrossRef Pum PB, Bhat AA, Mohan T et al (2009) Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses. Int Immunopharmacol 9(4):468–477CrossRef
14.
Zurück zum Zitat Corbctt TH, Griswold Jr, Robcrts BJ et al (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays with a note on carcinogen structure. Cancer Res 35(9):2434–2439 Corbctt TH, Griswold Jr, Robcrts BJ et al (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays with a note on carcinogen structure. Cancer Res 35(9):2434–2439
15.
Zurück zum Zitat Hyoudou K, Nishikawa M, Umeyama Y et al (2004) Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin Cancer Res 10(22):7685–7691PubMedCrossRef Hyoudou K, Nishikawa M, Umeyama Y et al (2004) Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin Cancer Res 10(22):7685–7691PubMedCrossRef
16.
Zurück zum Zitat Kawakami S, Sato A, Nishikawa M et al (2000) Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 7(4):292–299PubMedCrossRef Kawakami S, Sato A, Nishikawa M et al (2000) Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 7(4):292–299PubMedCrossRef
17.
Zurück zum Zitat Kuramoto Y, Nishikawa M, Hyoudou K et al (2006) Inhibition of peritoneal dissemination of tumor cells by single dosing of phosphodiester CpG oligonucleotide/cationic liposome complex. J Control Release 115(2):226–233PubMedCrossRef Kuramoto Y, Nishikawa M, Hyoudou K et al (2006) Inhibition of peritoneal dissemination of tumor cells by single dosing of phosphodiester CpG oligonucleotide/cationic liposome complex. J Control Release 115(2):226–233PubMedCrossRef
18.
Zurück zum Zitat Wijagkanalan W, Kawakami S, Takenaga M et al (2008) Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release 125(2):121–130PubMedCrossRef Wijagkanalan W, Kawakami S, Takenaga M et al (2008) Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release 125(2):121–130PubMedCrossRef
19.
Zurück zum Zitat Yoon TJ, Kim TJ, Lee H et al (2007) Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae. Int Immunopharmacol 8(1):36–42PubMedCrossRef Yoon TJ, Kim TJ, Lee H et al (2007) Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae. Int Immunopharmacol 8(1):36–42PubMedCrossRef
20.
Zurück zum Zitat Saiki I, Saito S, Fujita C et al (1998) Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues. Vaccine 6:238–244 Saiki I, Saito S, Fujita C et al (1998) Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues. Vaccine 6:238–244
21.
Zurück zum Zitat Yoon TJ, Yoo YC, Lee SW et al (2004) Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action. J Ethnopharmacol 93(2–3):247–253PubMedCrossRef Yoon TJ, Yoo YC, Lee SW et al (2004) Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action. J Ethnopharmacol 93(2–3):247–253PubMedCrossRef
22.
Zurück zum Zitat Yoon TJ, Yoo YC, Kang TB et al (1998) Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumor metastasis is mediated by enhancement of NK cell activity. Int J Immunopharmacol 20(4–5):163–172PubMedCrossRef Yoon TJ, Yoo YC, Kang TB et al (1998) Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumor metastasis is mediated by enhancement of NK cell activity. Int J Immunopharmacol 20(4–5):163–172PubMedCrossRef
23.
Zurück zum Zitat Kitchens WH, Chase CM, Uehara S et al (2007) Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 7(12):2675–2682PubMedCrossRef Kitchens WH, Chase CM, Uehara S et al (2007) Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 7(12):2675–2682PubMedCrossRef
24.
Zurück zum Zitat Gregoire C, Chasson L, Luci C et al (2007) The trafficking of natural killer cells. Immunol Rev 220:169–182PubMedCrossRef Gregoire C, Chasson L, Luci C et al (2007) The trafficking of natural killer cells. Immunol Rev 220:169–182PubMedCrossRef
26.
Zurück zum Zitat Bahjat KS, Prell RA, Allen HE et al (2007) Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease. J Immunol 179(11):7376–7384PubMed Bahjat KS, Prell RA, Allen HE et al (2007) Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease. J Immunol 179(11):7376–7384PubMed
27.
Zurück zum Zitat Sivori S, Falco M, Della Chiesa M et al (2004) CpG and double-stranded RNA trigger human NK cells by toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101(27):10116–10121PubMedCrossRef Sivori S, Falco M, Della Chiesa M et al (2004) CpG and double-stranded RNA trigger human NK cells by toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101(27):10116–10121PubMedCrossRef
28.
Zurück zum Zitat Paget C, Bialecki E, Fontaine J et al (2009) Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. J Immunol 182(4):1846–1853PubMedCrossRef Paget C, Bialecki E, Fontaine J et al (2009) Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. J Immunol 182(4):1846–1853PubMedCrossRef
29.
Zurück zum Zitat Lysaght J, Jarnicki AG, Mills KH (2007) Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity. Cancer Immunol Immunother 56(9):1367–1379PubMedCrossRef Lysaght J, Jarnicki AG, Mills KH (2007) Reciprocal effects of Th1 and Treg cell inducing pathogen-associated immunomodulatory molecules on anti-tumor immunity. Cancer Immunol Immunother 56(9):1367–1379PubMedCrossRef
30.
Zurück zum Zitat Shindo H, Ogura T, Masuno T et al (1985) Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice. Cancer Immunol Immunother 20(2):145–15025PubMedCrossRef Shindo H, Ogura T, Masuno T et al (1985) Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice. Cancer Immunol Immunother 20(2):145–15025PubMedCrossRef
31.
Zurück zum Zitat Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7(3):211–217PubMedCrossRef Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7(3):211–217PubMedCrossRef
32.
Zurück zum Zitat Coffelt SB, Hughes R, Lewis CE (2009) Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 1796(1):11–18PubMed Coffelt SB, Hughes R, Lewis CE (2009) Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 1796(1):11–18PubMed
33.
Zurück zum Zitat Zeisberger SM, Odermatt B, Marty C et al (2006) Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95:272–281PubMedCrossRef Zeisberger SM, Odermatt B, Marty C et al (2006) Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95:272–281PubMedCrossRef
34.
Zurück zum Zitat Suzuki K, Suda T, Naito T et al (2005) Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA. Am J Respir Crit Care Med 171(7):707–713PubMedCrossRef Suzuki K, Suda T, Naito T et al (2005) Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA. Am J Respir Crit Care Med 171(7):707–713PubMedCrossRef
Metadaten
Titel
The involvement of NK cell activation following intranasal administration of CpG DNA lipoplex in the prevention of pulmonary metastasis and peritoneal dissemination in mice
verfasst von
Shuwen Zhou
Shigeru Kawakami
Yuriko Higuchi
Fumiyoshi Yamashita
Mitsuru Hashida
Publikationsdatum
01.01.2012
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 1/2012
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-011-9429-1

Weitere Artikel der Ausgabe 1/2012

Clinical & Experimental Metastasis 1/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.